Crowd-sourced and expert video assessment in minimally invasive esophagectomy.

Journal Information

Full Title: Surg Endosc

Abbreviation: Surg Endosc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations DisclosuresMirte Ketel, Bastiaan Klarenbeek, Camiel Rosman, Yassin Eddahchouri, and Frans van Workum declare funding from Ethicon for the submitted work. However, Ethicon as sponsor had no role in the design and conduct of the study: collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Both Camiel Rosman and Bastiaan Klarenbeek report grants from Medtronic and Bastiaan Klarenbeek reports grants from ZonMW, Stichting Bergh in het Zadel, BeNeFit, Stichting Sasha Swartouw, and Radboud Oncology Fund outside of the submitted work. In addition, C-SATS donated the use of their product for the completion of this study. Elke van Daele reports a study grant ‘Kom op tegen kanker’ outside of the submitted work. Christian Gutschow received speaker honoraria: BD/Bard Medical, Johnson & Johnson, B. Braun/Aesculap, Micro-Tech Europe GmbH, and Bristol-Myers Squibb; Consulting fees: BD/Bard Medical and Medtronic; and Research grant: B. Braun/Aesculap, all outside of the submitted work. Misha Luyer received consulting fees from Medtronic and Galvani, outside of the submitted work. Robert Merritt received consulting fees from Astra Zeneca as advisory board and Honoria from Intuitive Surgical for lectures, all outside of the submitted work. Grard Nieuwenhuijzen received consulting fees from Medtronic, outside of the submitted work. Inger Abma, Miguel Cuesta, Michal Hubka, Arnulf Hölscher, and Yaxing Shen have no conflicts of interest or financial ties to disclose. Disclosures Mirte Ketel, Bastiaan Klarenbeek, Camiel Rosman, Yassin Eddahchouri, and Frans van Workum declare funding from Ethicon for the submitted work. However, Ethicon as sponsor had no role in the design and conduct of the study: collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Both Camiel Rosman and Bastiaan Klarenbeek report grants from Medtronic and Bastiaan Klarenbeek reports grants from ZonMW, Stichting Bergh in het Zadel, BeNeFit, Stichting Sasha Swartouw, and Radboud Oncology Fund outside of the submitted work. In addition, C-SATS donated the use of their product for the completion of this study. Elke van Daele reports a study grant ‘Kom op tegen kanker’ outside of the submitted work. Christian Gutschow received speaker honoraria: BD/Bard Medical, Johnson & Johnson, B. Braun/Aesculap, Micro-Tech Europe GmbH, and Bristol-Myers Squibb; Consulting fees: BD/Bard Medical and Medtronic; and Research grant: B. Braun/Aesculap, all outside of the submitted work. Misha Luyer received consulting fees from Medtronic and Galvani, outside of the submitted work. Robert Merritt received consulting fees from Astra Zeneca as advisory board and Honoria from Intuitive Surgical for lectures, all outside of the submitted work. Grard Nieuwenhuijzen received consulting fees from Medtronic, outside of the submitted work. Inger Abma, Miguel Cuesta, Michal Hubka, Arnulf Hölscher, and Yaxing Shen have no conflicts of interest or financial ties to disclose."

Evidence found in paper:

"Funding This study was funded via the investigator-initiated study proposal rewarded by Ethicon Endo-Surgery by Johnson & Johnson Medical Limited. The study was performed independently, and Ethicon had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit to manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025